Business Wire·Nov 7, 2025, 7:00 AM ET

agilon Announces Receipt of Notice of Non-Compliance with the NYSE Continued Listing Standards

Agilon Health, Inc. (NYSE: AGL) received a notice from the NYSE on November 5, 2025, stating it is non-compliant because its stock price averaged less than $1.00 per share over 30 consecutive trading days ending November 4, 2025.
The non-compliance notice has no immediate impact on the company's listing or trading status, as the stock will continue to trade during a cure period.
The notice is not expected to affect the company's ongoing business operations or its reporting requirements with the SEC.
Agilon Health plans to notify the NYSE by November 19, 2025, of its intent to remain listed.
To regain compliance with the $1.00 price criteria, the company intends to pursue a reverse stock split subject to shareholder approval.
The company expects to seek stockholder approval for the reverse stock split at its annual general meeting in 2026.
Agilon Health operates as a partner empowering physician groups to transition to a value-based Total Care Model for senior patients across 30 communities.